Valor Intrínseco del S&P y Nasdaq Contáctenos

Oncotelic Therapeutics, Inc. OTLC OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score
22/100
0/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Ha habido 50 transacciones internas recientes registradas para Oncotelic Therapeutics, Inc. (OTLC), incluyendo 38 compras y 10 ventas. El total de compras internas fue valorado en $948.56K y el total de ventas internas en RSU Award.

Internos destacados con actividad reciente incluyen Trieu Vuong, King Steven W, Maida Anthony E Iii. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.

Operaciones de Insiders — OTLC

Fecha Nombre Cargo Tipo de Transacción Acciones Precio Promedio Valor Acciones en Propiedad
2025-01-31 Trieu Vuong 10 Percent Owner, Officer: Chairman and CEO Compra Informativa 63,775 $0.03 $1.79K 93,189,560
2025-01-30 Trieu Vuong 10 Percent Owner, Officer: Chairman and CEO Compra Informativa 100,003 $0.03 $2.8K 93,125,785
2025-01-29 Trieu Vuong 10 Percent Owner, Officer: Chairman and CEO Compra Informativa 183,066 $0.03 $5.13K 93,025,782
2024-11-22 Trieu Vuong 10 Percent Owner, Officer: Chairman and CEO Compra Informativa 298,499 $0.03 $8.63K 92,842,716
2024-08-23 Trieu Vuong 10 Percent Owner, Officer: Chairman and CEO Compra Informativa 500,000 $0.02 $10K 92,544,217
2023-06-29 Trieu Vuong 10 Percent Owner, Officer: Chairman and CEO Compra Informativa 425,000 $0.02 $8.93K 92,044,217
2023-06-28 Trieu Vuong 10 Percent Owner, Officer: Chairman and CEO Compra Informativa 75,000 $0.03 $1.95K 91,619,217
2023-06-16 Trieu Vuong 10 Percent Owner, Officer: Chairman and CEO Compra Informativa 100,000 $0.03 $2.6K 91,544,217
2023-06-14 Trieu Vuong 10 Percent Owner, Officer: Chairman and CEO Compra Informativa 400,000 $0.03 $13.04K 91,444,217
2023-05-26 Trieu Vuong 10 Percent Owner, Officer: Chairman and CEO Compra Informativa 126,888 $0.03 $4.33K 91,044,217
2023-05-02 Trieu Vuong 10 Percent Owner, Officer: Chairman and CEO Compra Informativa 100,000 $0.05 $4.5K 90,917,329
2022-12-06 Trieu Vuong Chairman and CEO Compra Informativa 120,000 $0.05 $6K 90,558,021
2022-11-22 Trieu Vuong Chairman and CEO Compra Informativa 70,000 $0.08 $5.6K 90,438,021
2022-09-26 Trieu Vuong 10 Percent Owner, Officer: Chairman and CEO Compra Informativa 20,000 $0.07 $1.36K 90,368,021
2022-08-25 Trieu Vuong Chairman and CEO Compra Informativa 80,000 $0.08 $6.56K 90,348,021
2021-09-03 King Steven W Director Concesión de RSU 500,000 $0.14 $69.65K 500,000
2021-09-03 Maida Anthony E Iii Chief Clin. Ops. Officer Concesión de RSU 600,000 $0.14 $83.58K 600,000
2021-09-03 Trieu Vuong Chief Executive Officer Concesión de RSU 225,000 - - 225,000
2021-09-03 Saund Saran Chief Business Officer Concesión de RSU 675,000 $0.14 $94.03K 675,000
2021-07-08 King Steven W Director Concesión de RSU 357,412 $0.16 $58.12K 357,412
2021-07-08 Maida Anthony E Iii Chief Clinical Officer Concesión de RSU 400,000 $0.16 $65.04K 400,000
2021-07-08 Trieu Vuong 10 Percent Owner, Officer: Chairman and CEO Concesión de RSU 513,953 $0.16 $83.57K 513,953
2021-07-08 Shah Amit B. Chief Financial Officer Concesión de RSU 298,837 - - 358,837
2021-07-08 Diamond David Director Concesión de RSU 451,467 $0.16 $73.41K 451,467
2021-07-08 Saund Saran Chief Business Officer Concesión de RSU 216,279 $0.16 $35.17K 216,279
2021-03-31 King Steven W Director Conversión (Venta) 3,292 - - -
2021-03-31 Maida Anthony E Iii Chief Clinical Officer Conversión (Venta) 938 - - -
2021-03-31 Trieu Vuong 10 Percent Owner, Officer: Chairman and CEO Conversión (Venta) 5,672 - - -
2021-03-31 Saund Saran Chief Business Officer Conversión (Venta) 16,355 - - -
2020-11-24 Shah Amit B. Chief Financial Officer Compra Informativa 8,220 $0.19 $1.56K 60,000
2020-11-23 Shah Amit B. Chief Financial Officer Compra Informativa 20,088 $0.19 $3.82K 51,780
2020-11-20 Shah Amit B. Chief Financial Officer Compra Informativa 31,692 $0.20 $6.18K 31,692
2020-11-19 Trieu Vuong Chief Executive Officer Compra Informativa 50,500 $0.19 $9.6K 15,812,308
2020-11-19 Park Chulho Chief Technology Officer Compra Informativa 22,173 $0.18 $4.1K 2,833,992
2020-05-11 King Steven W Director Disposición 3,921,720 - - -
2020-05-11 Maida Anthony E Iii Director Disposición 938,646 - - -
2020-03-26 Trieu Vuong Chief Executive Officer Compra Informativa 3,000 $0.12 $360.00 15,761,808
2020-01-22 Diamond David Officer Desconocido - - - -
2019-04-22 Trieu Vuong 10 Percent Owner, Officer: CEO and Chairman of the Board Desconocido 5,672,025 - - -
2019-04-22 Hwang Larn 10 Percent Owner Disposición 19,350,411 - - -
2019-04-22 Hsiao Chao 10 Percent Owner Disposición 14,070,529 - - -
2019-04-22 Uckun Fatih 10 Percent Owner, Officer: Chief Medical Officer Disposición 7,052,762 - - -
2019-04-22 Park Chulho 10 Percent Owner, Officer: Chief Technical Officer Disposición 13,285,013 - - -
2018-06-20 Sandage Bobby W. Jr., Phd. Director Concesión de RSU 258,171 $0.22 $56.8K 258,171
2018-06-20 Chaplin David Director Concesión de RSU 258,171 $0.22 $56.8K 258,171
2018-06-20 Loar Matthew M Chief Financial Officer Concesión de RSU 250,000 - - 250,000
2018-06-20 Pedder Simon Director Concesión de RSU 258,171 $0.22 $56.8K 258,171
2018-06-20 Schwieterman William D President and CEO Concesión de RSU 500,000 - - 500,000
2018-06-20 Reynolds Donald Rogers Director Concesión de RSU 258,171 $0.22 $56.8K 258,171
2018-04-12 Loar Matthew M Chief Financial Officer Compra Informativa 125,000 $0.40 $50K 125,000
Informativa — transacción en mercado abierto (más significativa) No informativa (compra) — premio, ejercicio de opción, conversión No informativa (venta) — retención fiscal, venta de adjudicación Neutral — regalo, fideicomiso, vencimiento
Contáctenos
🎓
SharesGrow Academia
Aprende a calcular el Valor Intrínseco y encontrar acciones infravaloradas.
Sesiones semanales en vivo
Envíanos un mensaje